{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:42:27Z","timestamp":1787773347072,"version":"build-2784847793"},"reference-count":46,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["22K11804"],"award-info":[{"award-number":["22K11804"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Estimated remnant cholesterol (Rem-C) level, a risk factor for cardiovascular disease, is associated with metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosed via ultrasonography. However, the relationship between accurate serum Rem-C level measurements and histological findings of MASLD remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to elucidate the relationship between accurately measured serum Rem-C levels and histological findings of MASLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional single-center observational study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We assessed 222 patients (94 men and 128 women; age 20-80) who were diagnosed with MASLD via liver biopsy with available medical history, physical examination, and biochemical measurement data. Serum ester-type cholesterol and free cholesterol contents in the remnant lipoproteins were measured using an enzymatic method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum Rem-C levels were significantly higher in patients with NAFLD activity score (NAS) 5 to 8, &amp;gt;66% steatosis grade, lobular inflammation with \u22655 foci, and many cells\/prominent ballooning cells (a contiguous patch of hepatocytes showing prominent ballooning injury) than in patients with NAS 1 to 4, &amp;lt; 33% steatosis grade, lobular inflammation with &amp;lt;2 foci, and few ballooning cells (several scattered balloon cells), respectively. While univariate analysis revealed no significant association between Rem-C levels and advanced fibrosis, a significant association between Rem-C levels and NAS was evident. This relationship remained significant in multivariate analysis adjusted for confounders. Furthermore, in the analysis by sex, these relationships were significant for men but not for women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High serum Rem-C levels were associated with high NAS but not with fibrosis stage, particularly in men. Controlling serum Rem-C level may improve MASLD activity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae597","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T14:03:15Z","timestamp":1724853795000},"page":"e2064-e2070","source":"Crossref","is-referenced-by-count":7,"title":["Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-5356","authenticated-orcid":false,"given":"Teruki","family":"Miyake","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Health Services Center, Ehime University, 3 Bunkyocho , Matsuyama City, Ehime 790-0826 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunzo","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kanamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Nakaguchi","sequence":"additional","affiliation":[{"name":"Department of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhito","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tokumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Hirooka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teru","family":"Kumagi","sequence":"additional","affiliation":[{"name":"Postgraduate Medical Education Center, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hiasa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine , 454 Shitsukawa, Toon City, Ehime 791-0295 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"4","key":"2025052712543142400_dgae597-B1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.dsx.2018.03.016","article-title":"Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors","volume":"12","author":"Al-Dayyat","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"2025052712543142400_dgae597-B2","doi-asserted-by":"crossref","first-page":"d6891","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study","volume":"343","author":"Lazo","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"2025052712543142400_dgae597-B3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"2025052712543142400_dgae597-B4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"2025052712543142400_dgae597-B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"2025052712543142400_dgae597-B6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"2025052712543142400_dgae597-B7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"2025052712543142400_dgae597-B8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","article-title":"Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease","volume":"36","author":"Varbo","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2025052712543142400_dgae597-B9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2025052712543142400_dgae597-B10","doi-asserted-by":"crossref","first-page":"e002765","DOI":"10.1161\/JAHA.115.002765","article-title":"Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson Heart and Framingham Offspring Cohort studies","volume":"5","author":"Joshi","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2025052712543142400_dgae597-B11","first-page":"452","article-title":"Remnant-like particle cholesterol and the risk of major adverse cardiovascular events: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"issue":"6","key":"2025052712543142400_dgae597-B12","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","article-title":"Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents","volume":"2","author":"Chin","year":"2020","journal-title":"JHEP Rep"},{"issue":"4","key":"2025052712543142400_dgae597-B13","doi-asserted-by":"crossref","first-page":"e1598","DOI":"10.1210\/clinem\/dgab825","article-title":"Remnant lipoprotein cholesterol as a factor related to adult fatty liver disease","volume":"107","author":"Zhang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025052712543142400_dgae597-B14","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/clinem\/dgad272","article-title":"Remnant cholesterol independently predicts the development of nonalcoholic fatty liver disease","volume":"108","author":"Huang","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025052712543142400_dgae597-B15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13098-023-01220-9","article-title":"Remnant cholesterol and severity of nonalcoholic fatty liver disease","volume":"15","author":"Huang","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"2025052712543142400_dgae597-B16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/00365521.2023.2294693","article-title":"Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease","volume":"59","author":"Wang","year":"2024","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2025052712543142400_dgae597-B17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"2025052712543142400_dgae597-B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"12","key":"2025052712543142400_dgae597-B19","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1373\/clinchem.2007.092296","article-title":"Development of a homogeneous assay to measure remnant lipoprotein cholesterol","volume":"53","author":"Miyauchi","year":"2007","journal-title":"Clin Chem"},{"key":"2025052712543142400_dgae597-B20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","article-title":"Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"key":"2025052712543142400_dgae597-B21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.puhe.2016.04.005","article-title":"Hepatitis C and risk of coronary atherosclerosis\u2013A systematic review","volume":"138","author":"Olubamwo","year":"2016","journal-title":"Public Health"},{"issue":"6","key":"2025052712543142400_dgae597-B22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"2025052712543142400_dgae597-B23","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/biomedicines10102540","article-title":"Plasma fatty acid composition is associated with histological findings of nonalcoholic steatohepatitis","volume":"10","author":"Miyake","year":"2022","journal-title":"Biomedicines"},{"key":"2025052712543142400_dgae597-B24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","article-title":"Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor","volume":"299","author":"Konishi","year":"2020","journal-title":"Atherosclerosis"},{"key":"2025052712543142400_dgae597-B25","unstructured":"Miyake T, Furukawa S, Matsuura B, et al \u00a0Supplementary Table from: Association between serum remnant cholesterol level and metabolic dysfunction-associated steatotic liver histology. Figshare. Deposited September 12, 2024. DOI:10.6084\/m9.figshare.27000202."},{"issue":"1","key":"2025052712543142400_dgae597-B26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4093\/dmj.2013.37.1.63","article-title":"Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease","volume":"37","author":"Choi","year":"2013","journal-title":"Diabetes Metab J"},{"issue":"4","key":"2025052712543142400_dgae597-B27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"\u03b12-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"2025052712543142400_dgae597-B28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1042\/bj2740899","article-title":"Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin","volume":"274","author":"Haasemann","year":"1991","journal-title":"Biochem J"},{"issue":"5","key":"2025052712543142400_dgae597-B29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab"},{"issue":"12","key":"2025052712543142400_dgae597-B30","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3945\/jn.108.094516","article-title":"Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution","volume":"138","author":"van Hees","year":"2008","journal-title":"J Nutr"},{"issue":"2","key":"2025052712543142400_dgae597-B31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2362.2002.00945.x","article-title":"Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner","volume":"32","author":"Panarotto","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2025052712543142400_dgae597-B32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"issue":"11","key":"2025052712543142400_dgae597-B33","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.3390\/cimb45110570","article-title":"The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease-the transition from an adipocentric to liver-centric approach","volume":"45","author":"Veskovi\u0107","year":"2023","journal-title":"Curr Issues Mol Biol"},{"issue":"13","key":"2025052712543142400_dgae597-B34","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/jcm11133649","article-title":"The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications","volume":"11","author":"Palma","year":"2022","journal-title":"J Clin Med"},{"issue":"6","key":"2025052712543142400_dgae597-B35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-58-6-1125","article-title":"Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow","volume":"58","author":"Nosadini","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2025052712543142400_dgae597-B36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(63)80130-4","article-title":"Capillarization of hepatic sinusoids in man","volume":"44","author":"Schaffner","year":"1963","journal-title":"Gastroenterology"},{"issue":"6","key":"2025052712543142400_dgae597-B37","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.26072","article-title":"Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?","volume":"57","author":"van der Poorten","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"2025052712543142400_dgae597-B38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ajcn\/69.6.1066","article-title":"Effect of cirrhosis on energy expenditure","volume":"69","author":"McCullough","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2025052712543142400_dgae597-B39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1210\/jcem-54-6-1113","article-title":"High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel","volume":"54","author":"Tikkanen","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025052712543142400_dgae597-B40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0022-2275(20)38202-X","article-title":"Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women","volume":"30","author":"Applebaum-Bowden","year":"1989","journal-title":"J Lipid Res"},{"issue":"1","key":"2025052712543142400_dgae597-B41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0005-2760(90)90071-5","article-title":"Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats","volume":"1042","author":"Sultan","year":"1990","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2025052712543142400_dgae597-B42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"issue":"1","key":"2025052712543142400_dgae597-B43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol Commun"},{"issue":"11","key":"2025052712543142400_dgae597-B44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/jcm7110378","article-title":"Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease","volume":"7","author":"Pastori","year":"2018","journal-title":"J Clin Med"},{"issue":"12","key":"2025052712543142400_dgae597-B45","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.cgh.2020.11.005","article-title":"Clinical utility of change in nonalcoholic fatty liver disease activity score and change in fibrosis in NAFLD","volume":"19","author":"Tamaki","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2025052712543142400_dgae597-B46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2011.04.040","article-title":"Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals","volume":"218","author":"Nakamura","year":"2011","journal-title":"Atherosclerosis"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae597\/59150743\/dgae597.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/6\/e2064\/59150743\/dgae597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/6\/e2064\/59150743\/dgae597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:54:46Z","timestamp":1748364886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/6\/e2064\/7742940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8,28]]},"published-print":{"date-parts":[[2025,5,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae597","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,8,28]]}}}